Breaking News Instant updates and real-time market news.

YUMC

Yum China

$40.48

0.51 (1.28%)

12:43
10/06/17
10/06
12:43
10/06/17
12:43

Yum China upgraded to Buy after Q3 report at Deutsche Bank

As previously reported, Deutsche Bank analyst Anne Ling upgraded Yum China to Buy from Hold, as she sees the Q3 results as evidence that the company can still maintain its gross profit margin and improve its restaurant margins despite higher promotions. Ling, who raise her earnings estimates for Yum China, also increased her price target on the shares to $45.30 from $37.09.

YUMC Yum China
$40.48

0.51 (1.28%)

07/06/17
07/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Exxon Mobil (XOM) downgraded to Sector Perform from Outperform at RBC Capital with analyst Biraj Borkhataria saying Exxon's differentiated downstream positioning generates a significant portion of its free cash flow, but it is reflected in valuation. 2. O'Reilly Automotive (ORLY) downgraded to Neutral from Outperform at Credit Suisse and to Equal Weight from Overweight at Morgan Stanley. 3. Norfolk Southern (NSC) downgraded to Sector Perform from Outperform at Scotiabank. 4. Yum China (YUMC) downgraded to Hold from Buy at Deutsche Bank with analyst Anne Ling citing the company's second quarter results. 5. Tahoe Resources (TAHO) downgraded to Market Perform from Outperform at BMO Capital and to Hold from Buy at TD Securities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/17
MSCO
07/12/17
NO CHANGE
Target $41
MSCO
Overweight
Morgan Stanley remains bullish on Yum China
Yum China analyst John Glass said he remains bullish on Yum China following the Q2 "exaggerated" selloff. The analyst said the shares were week due to strong share performance since the Q1 report, a mixed shareholder base, high comp expectations, and vague second half margin guidance. Glass remains optimistic and reiterated his Overweight rating and $41 price target on Yum China given expectations KFC comps can accelerate further in the second half, margin expansion, and said long-term margin goal of 17% appears conservative.
09/21/17
SBSH
09/21/17
INITIATION
Target $51
SBSH
Buy
Yum China initiated with a Buy at Citi (Monday)
Citi analyst Xiaopo Wei on Monday started Yum China with a Buy rating and $51 price target. With over 2B annual customer visits to its restaurants, the company "has very few equals as a play on China consumption," Wei told investors in a research note.
10/06/17
DBAB
10/06/17
UPGRADE
DBAB
Buy
Yum China upgraded to Buy from Hold at Deutsche Bank

TODAY'S FREE FLY STORIES

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

07:08
09/24/18
09/24
07:08
09/24/18
07:08
Recommendations
Nightstar Therapeutics analyst commentary  »

Nightstar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 03

    Oct

LGND

Ligand

$260.52

3.01 (1.17%)

07:08
09/24/18
09/24
07:08
09/24/18
07:08
Conference/Events
Ligand management to meet with Stephens »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 06

    Nov

INBK

First Internet Bancorp

$31.05

-0.55 (-1.74%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Conference/Events
First Internet Bancorp management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 15

    Nov

MDWD

MediWound

$6.40

(0.00%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Hot Stocks
MediWound awarded additional BARDA contract valued up to $43M »

MediWound announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

SRPT

Sarepta

$147.81

-5.105 (-3.34%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Hot Stocks
Sarepta announces FDA lift of clinical hold on DMD micro-dystrophin gene program »

Sarepta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFN

General Finance Corp

$14.20

(0.00%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Hot Stocks
General Finance Corp unit to acquire assets of Instant Storage »

General Finance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$337.80

0.09 (0.03%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Conference/Events
Humana management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

LOOP

Loop Industries

$9.49

0.84 (9.71%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Hot Stocks
Loop Industries, Indorama ventures JV to manufacter sustainable polyester resin »

Indorama Ventures Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MD

Mednax

$45.60

-1.91 (-4.02%)

07:05
09/24/18
09/24
07:05
09/24/18
07:05
Upgrade
Mednax rating change  »

Mednax upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBP

First BanCorp

$9.17

0.14 (1.55%)

07:05
09/24/18
09/24
07:05
09/24/18
07:05
Conference/Events
First BanCorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 25

    Oct

07:05
09/24/18
09/24
07:05
09/24/18
07:05
General news
Oil Action: Front-month WTI crude prices are up 1.6% »

Oil Action: Front-month…

KRYS

Krystal Biotech

$16.88

-0.37 (-2.14%)

07:04
09/24/18
09/24
07:04
09/24/18
07:04
Initiation
Krystal Biotech initiated  »

Krystal Biotech initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

ACRS

Aclaris Therapeutics

$15.18

-0.24 (-1.56%)

07:04
09/24/18
09/24
07:04
09/24/18
07:04
Hot Stocks
Aclaris Therapeutics initiates Phase 3 wart program for A-101 »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

T

AT&T

$33.88

0.44 (1.32%)

07:03
09/24/18
09/24
07:03
09/24/18
07:03
Recommendations
AT&T analyst commentary  »

Deutsche Bank adds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

P

Pandora

$9.08

-0.31 (-3.30%)

07:03
09/24/18
09/24
07:03
09/24/18
07:03
Earnings
Pandora backs Q3 revenue view $390M-$405M, consensus $401.45M »

Pandora reiterated its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Earnings
Sirius XM backs FY18 guidance for revenue of over $5.7B, consensus $5.76B »

SiriusXM reiterated its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

EPZM

Epizyme

$10.30

-0.1 (-0.96%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Conference/Events
Epizyme to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 02

    Oct

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Hot Stocks
Sirius XM to acquire Pandora in all-stock transaction valuing Pandora at $3.5B »

Sirius XM Holdings (SIRI)…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MYL

Mylan

$38.98

0.25 (0.65%)

07:01
09/24/18
09/24
07:01
09/24/18
07:01
Hot Stocks
Mylan, Atomo Diagnostics announce strategic partnership »

Mylan and Atomo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BLK

BlackRock

$488.00

0.94 (0.19%)

, PAM

Pampa Energia

$37.79

1.09 (2.97%)

07:01
09/24/18
09/24
07:01
09/24/18
07:01
Periodicals
BlackRock, other funds circle troubled Argentine companies, Bloomberg says »

BlackRock (BLK), Carval…

BLK

BlackRock

$488.00

0.94 (0.19%)

PAM

Pampa Energia

$37.79

1.09 (2.97%)

YPF

YPF

$17.04

-0.1 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 17

    Oct

MD

Mednax

$45.60

-1.91 (-4.02%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Upgrade
Mednax rating change  »

Mednax upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Hot Stocks
Breaking Hot Stocks news story on Sirius XM, Pandora »

Sirius XM to acquire…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BIO

Bio-Rad

$298.45

-2.74 (-0.91%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Recommendations
Bio-Rad analyst commentary  »

Jefferies boosts Bio-Rad…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$2.44

0.035 (1.46%)

, NUS

Nu Skin

$84.46

0.6 (0.72%)

06:58
09/24/18
09/24
06:58
09/24/18
06:58
Upgrade
Avon Products, Nu Skin, Herbalife Nutrition rating change  »

Avon Products upgraded to…

AVP

Avon Products

$2.44

0.035 (1.46%)

NUS

Nu Skin

$84.46

0.6 (0.72%)

HLF

Herbalife Nutrition

$54.98

-0.05 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

IDXG

Interpace Diagnostics

$1.53

-0.11 (-6.71%)

06:57
09/24/18
09/24
06:57
09/24/18
06:57
Hot Stocks
Interpace Diagnostics approved to lauch newest thyroid product, ThyGeNEXT »

Interpace Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.